Azepan-4-ol hydrochloride

Catalog No.: 
ACPHXA463
CAS No.: 
1159823-34-3
Molecular Formula: 
C6H14ClNO
Molecular Weight: 
151.64
Azepan-4-ol hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$54.00In stockInquiry
5g98%$191.00In stockInquiry
25g98%$782.00In stockInquiry
100g98%$2715.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAzepan-4-ol hydrochloride
IUPAC Nameazepan-4-ol hydrochloride
MDL No.MFCD11053644
Molecular FormulaC6H14ClNO
Molecular Weight151.64
SMILESOC1CCNCCC1.[H]Cl
InChI KeyUQYAGKOXTPXDMW-UHFFFAOYSA-N
SynonymAM802973 | SB35843 | 1159823-34-3 | Z1198309797 | Hexahydro-1H-azepin-4-ol HCl | UQYAGKOXTPXDMW-UHFFFAOYSA-N | 1H-Azepin-4-ol, hexahydro-, hydrochloride (1:1) | AKOS015998681 | SB30924 | SCHEMBL322116 | SY123069 | Azepan-4-ol hydrochloride | DTXSID7069487
CAS No.1159823-34-3
PubChem CID53401279

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPHXA463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCHLD950 route compound structure diagram
    ACCHLD95050492-22-3In Stock
  2. Then
  3. ACPHXA463 route product structure diagram
    ACPHXA4631159823-34-3In Stock
Inquiry

2. ACPHXA463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCXBA018 route compound structure diagram
    ACCXBA01883621-33-4In Stock
  2. Then
  3. ACPHXA463 route product structure diagram
    ACPHXA4631159823-34-3In Stock
Inquiry

3. ACPHXA463 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSPXF927 route compound structure diagram
    ACSPXF927648418-25-1In Stock
  2. Then
  3. ACPHXA463 route product structure diagram
    ACPHXA4631159823-34-3In Stock
Inquiry

Comments (0)